2021 annual financial data
Emergent BioSolutions 2021 Operating margin
Emergent BioSolutions 2021 operating margin with verified reported values.
Direct answer
Operating margin was 19.25%.
Operating income was 341,400,000 USD and net income was 219,500,000 USD.
Operating cash flow was 321,100,000 USD.
Get free Emergent BioSolutions email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,773,600,000 USD
- Operating income
- 341,400,000 USD
- Net income
- 219,500,000 USD
- Operating cash flow
- 321,100,000 USD